Chief Commercial Officer · FENNEC PHARMACEUTICALS INC. · Common Shares
Side
M
Value
—
Shares
168
Price
—
Executed
Apr 30, 2026
Disclosed
May 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 30 executedMay 1, 2026 disclosed
FENC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · 0.8% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Evans Terry L filed this Form 4 reporting a option exercise of FENC on Apr 30, 2026. It became public on May 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Evans Terry Lcik:0002043317
Issuer
FENNEC PHARMACEUTICALS INC.cik:0001211583
Revision history · 0
No field has changed since this record was first ingested.
